1. Home
  2. Advocacy
  3. Latest News and Practice Data
  4. Common Questions Answered About the CAP’s Amicus Brief on LDTs

Common Questions Answered About the CAP’s Amicus Brief on LDTs

Oct 15, 2024

Our laboratory-developed test (LDT) oversight FAQ webpage now includes commonly asked and answered questions about the CAP’s amicus brief court filing from October 7.

In the amicus brief, the CAP urged a US Federal District Court to vacate the FDA regulation for several reasons, including the ultimate impact on patient access to these critically important diagnostic tests and the FDA failing to adequately justify the rule’s unsustainable costs that will hinder the development of LDTs.

Most Recent Content

  1. July 1, 2025
    Advocacy Updates Advocacy Updates
    Jul 1, 2025
  2. What’s in the Senate's "One Big Beautiful Bill"
    Advocacy Updates Advocacy Updates
    Jul 1, 2025
  3. CMS eases lab personnel rules with new guidance
    Advocacy Updates Advocacy Updates
    Jul 1, 2025
  4. Lab groups: Bring back CLIAC
    Advocacy Updates Advocacy Updates
    Jul 1, 2025
  5. Supreme Court backs no-cost preventive care panel
    Advocacy Updates Advocacy Updates
    Jul 1, 2025
  6. View All
To Top